Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
==========================================================================================================================================

* Asha Nayak-Kapoor
* Zhonglin Hao
* Ramses Sadek
* Robin Dobbins
* Lisa Marshall
* Nicholas N. Vahanian
* W. Jay Ramsey
* Eugene Kennedy
* Mario R. Mautino
* Charles J. Link
* Ray S. Lin
* Stephanie Royer-Joo
* Xiaorong Liang
* Laurent Salphati
* Kari M. Morrissey
* Sami Mahrus
* Bruce McCall
* Andrea Pirzkall
* David H. Munn
* John E. Janik
* Samir N. Khleif